Unique ID issued by UMIN | UMIN000009676 |
---|---|
Receipt number | R000011349 |
Scientific Title | The effects of preventive interventions for constipation during breast cancer chemotherapy: a pilot study |
Date of disclosure of the study information | 2012/12/31 |
Last modified on | 2014/05/12 22:18:38 |
The effects of preventive interventions for constipation during breast cancer chemotherapy: a pilot study
Constipation preventive efficacy study for breast cancer
The effects of preventive interventions for constipation during breast cancer chemotherapy: a pilot study
Constipation preventive efficacy study for breast cancer
Japan |
Constipation with breast cancer therapy
Breast surgery | Rehabilitation medicine |
Malignancy
NO
To clarify whether the instructions of the nonpharmacological constipation prevention method (massage, exercises, excretion method) bring effects for constipation with the breast cancer chemotherapy.
Efficacy
Exploratory
Pragmatic
Not applicable
Constipation
(Score of Constipation assessment scale)
defecation
use of laxative
QOL
mood and emotional state
sleep activity rhythm
Action
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
YES
NO
Institution is not considered as adjustment factor.
YES
2
Prevention
Behavior,custom | Maneuver |
the instruction of the constipation prevention method (massage, exercises, excretion method)for one week on the chemotherapy day before.
the instruction of the constipation prevention method (massage, exercises, excretion method) on the next chemotherapy day.
20 | years-old | <= |
Not applicable |
Female
all the following conditions
(1)Admit into the Kyoto University hospital for breast cancer treatment and receiving chemotherapy
(2)Control emesis by the 5-HT3 receptor antagonist which include Ondansetron, Granisetron, Tropisetron, Palonosetron, before chemotherapy.
(3)Performance Status 0 or 1
(4)able to defecate with normal digestive organ and trunk function
(5)Signed informed consent for this study
(1)Difficult to accept the researcher by mental disorder, cognitive impairment or physical disability
(2)Constipation before chemotherapy; higher than CTCAEv4.0 Grade2 (Persistent symptoms with regular use of axatives or enemas; limiting instrumental ADL)
(3)Pregnant
(4)Have difficulty in active exercise in physician judgement
(5)Inappropriate for this study in physician judgement
(5)In the chemotherapy term, it is necessary to continue aperient or supplement except our prescription in physician judgement
30
1st name | |
Middle name | |
Last name | Akira Mitani |
Kyoto university graduate school of medicine
Clinical Cognitive Neuroscience
53, Syogoinkawaharacho, Sakyo-ku, Kyoto-shi, Kyoto
1st name | |
Middle name | |
Last name | Akiko Hanai |
Kyoto university graduate school of medicine
Clinical Cognitive Neuroscience
53, Syogoinkawaharacho, Sakyo-ku, Kyoto-shi, Kyoto
075-751-3944
hanai.akiko.44w@st.kyoto-u.ac.jp
Kyoto university graduate school of medicine
Kyoto university graduate school of medicine
Other
Cancer professional training base promotion plan
NO
京都大学医学部附属病院(京都府)
2012 | Year | 12 | Month | 31 | Day |
Unpublished
Completed
2012 | Year | 12 | Month | 17 | Day |
2013 | Year | 01 | Month | 10 | Day |
2012 | Year | 12 | Month | 31 | Day |
2014 | Year | 05 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011349
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |